Hi Rae915,
$1 a lofty estimate given upcoming catalysts and revenue projection. I’ll be cool with $0.6-$0.7 Dec’24 but when Remplir gets US approval Q1/2 2025 I anticipate we should really see a climb towards $1.2-$1.5 range and then ideally $2-3 once we demonstrated a few quarters of profitability in early 2026.
My 2 cents and thesis, don’t mind a friendly gamble.
Was waiting on income later this month to load up on 35.5c and possibly double my relatively small 150K shares position. Train may have left the station unfortunately.
VFM
- Forums
- ASX - By Stock
- Ann: Regulatory Approval to Commence Sales for Striate in Canada
Hi Rae915,$1 a lofty estimate given upcoming catalysts and...
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
63.0¢ |
Change
0.005(0.80%) |
Mkt cap ! $150.6M |
Open | High | Low | Value | Volume |
63.5¢ | 65.0¢ | 61.5¢ | $327.9K | 519.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 26342 | 63.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.0¢ | 13231 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 26342 | 0.630 |
3 | 58274 | 0.625 |
4 | 83214 | 0.620 |
8 | 163623 | 0.615 |
6 | 117379 | 0.610 |
Price($) | Vol. | No. |
---|---|---|
0.640 | 13231 | 2 |
0.645 | 10000 | 1 |
0.650 | 10761 | 2 |
0.655 | 16000 | 1 |
0.660 | 10900 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online